LexDanaLexDanabeta
Inventor

JOHN STELLWAGEN

Inventor
US

Overview

5→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes29%
PatentTitleYear
12,570,672Macrocyclic compounds and methods of use202612,371,414Methods of treating neurological disorders202511,993,580Methods of treating neurological disorders202411,807,634Cyclopropyl dihydroquinoline sulfonamide compounds202311,332,459Benzimidazole derivatives and their uses2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to TEIJIN PHARMA LTD (1)· patent assignee history
2022–2026Based in US· patent location history
2023–2026Patents assigned to AMGEN INC (2)· patent assignee history
2024–2025Patents assigned to NEUMORA THERAPEUTICS INC (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AMGEN INC22023–2026
NEUMORA THERAPEUTICS INC22024–2025
TEIJIN PHARMA LTD12022
Locations
LocationPatentsSpan
US52022–2026